Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Edmond Chan"'
Autor:
Daqi Tu, Zehua Zhu, Alicia Y. Zhou, Cai-hong Yun, Kyung-Eun Lee, Angela V. Toms, Yiqun Li, Gavin P. Dunn, Edmond Chan, Tran Thai, Shenghong Yang, Scott B. Ficarro, Jarrod A. Marto, Hyesung Jeon, William C. Hahn, David A. Barbie, Michael J. Eck
Publikováno v:
Cell Reports, Vol 3, Iss 3, Pp 747-758 (2013)
Upon stimulation by pathogen-associated inflammatory signals, TANK-binding kinase 1 (TBK1) induces type I interferon expression and modulates nuclear factor κB (NF-κB) signaling. Here, we describe the 2.4 Å-resolution crystal structure of nearly f
Externí odkaz:
https://doaj.org/article/994a8e3a594e4cb5822df3147232d8d4
Autor:
Lori Minassian, Daniel Sanwalka, Jean-François Paré, Shannyn Macdonald-Goodfellow, R. Liam Sutherland, Abdi Ghaffari, Chelsea L. Margerum, Madhuri Koti, Andrew W.B. Craig, Tiziana Cotechini, D. Robert Siemens, Edmond Chan, Charles H. Graham
BackgroundWhile the Programmed Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) immune checkpoint is an important mechanism of immune evasion in cancer, recent studies have shown that it can also lead to resistance to chemotherapy in cancer cells via r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b2f1520b79c4e047523f68f7ee90f50
https://doi.org/10.1101/2023.01.17.524124
https://doi.org/10.1101/2023.01.17.524124
Background: Oral Food Challenges (OFC) confer the highest sensitivity and specificity in diagnosis; however, uptake has been variable across clinical settings. Numerous barriers were identified in literature from inadequate training to resource acces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86b73c161f2846b621842855523f84ae
https://doi.org/10.21203/rs.3.rs-2255249/v1
https://doi.org/10.21203/rs.3.rs-2255249/v1
Autor:
Christopher Trainer, Olivia R. Armitage, Harry Lane, Luke C. Rhodes, Edmond Chan, Izidor Benedičič, J. A. Rodriguez-Rivera, O. Fabelo, Chris Stock, Peter Wahl
Publikováno v:
Physical Review B. 106
Autor:
Edmond Chan, Mathieu Rosé, Massoud Toussi, Assem Al-Akabawi, Intissar Bourahla, Alessandro Ghiddi
Publikováno v:
Advances in Therapy. 38:2284-2293
Daratumumab, a monoclonal antibody targeting CD38, is approved to treat multiple myeloma. Red blood cells express low levels of CD38, which can result in a false-positive antibody screen in daratumumab-treated patients. Educational materials were dev
Autor:
Luca Delli Colli, Adnan M. Al Ali, Sofianne Gabrielli, Marina Delli Colli, Pasquale Mule, Benjamin Lawson, Ann E. Clarke, Judy Morris, Jocelyn Gravel, Rodrick Lim, Edmond Chan, Ran D. Goldman, Andrew O’Keefe, Jennifer Gerdts, Derek Chu, Julia Upton, Elana Hochstadter, Adam Bretholz, Christine McCusker, Xun Zhang, Shira Benor, Elinor Simons, Elissa Abrams, Jennifer LP Protudjer, Moshe Ben-Shoshan
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB200
Autor:
Lauren Perlman, Sofianne Gabrielli, Ann Clarke, Luca Delli Colli, Marina Delli Colli, Judy Morris, Jocelyn Gravel, Rod Lim, Edmond Chan, Ran Goldman, Andrew O'Keefe, Jennifer Gerdts, Derek Chu, Julia Upton, Elana Hochstadter, Jocelyn Moisan, Adam Bretholz, Christine McCusker, Xun Zhang, Jennifer Protudjer, Elissa Abrams, Elinor Simons, Moshe Ben-Shoshan
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB6
Autor:
Daniel Sehayek, Ann Clarke, Elissa Abrams, Adam Bretholz, Edmond Chan, Derek Chu, Jennifer Gerdts, Ran Goldman, Elana Hochstadter, Rodrick Lim, Christine McCusker, Jocelyn Moisan, Judy Morris, Andrew O’Keefe, Jennifer Protudjer, Elinor Simons, Julia Upton, Xun Zhang, Moshe Ben-Shoshan
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB11
Autor:
Benjamin Lawson, Luca Delli Colli, Sofianne Gabrielli, Bruce Mazer, null Danbing ke, Lydia Zhang, Duncan Lejtenyi, Chiara Lucchesi, Liane Beaudette, Julia Upton, Eyal Grunebaum, Ciriaco Piccirillo, Edmond Chan, Ann Clarke, Xun Zhang, Christine McCusker, Thomas Eiwegger, Moshe Ben-Shoshan
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB35